ARTICLE | Clinical News
Elobixibat regulatory update
February 8, 2017 10:46 PM UTC
Eisai’s EA Pharma Co. Ltd. subsidiary submitted an NDA in Japan for elobixibat to treat chronic constipation. EA has exclusive rights to elobixibat for gastrointestinal disorders in Japan and other As...